Formulation of fenofibrate capsules by dropping method using PEG 6000 and PEG 4000 to enhance solubility
1 Managing Director, Devansh Lab Werks Inc 234 Aquarius Drive, Suite111, Homewood, Alabama-35209, U. S.
2 Managing Director, Microgen Health, 14225 Sully Field Circle, Suite E, Chantilly, VA-20151.
3 Narasaraopeta Institute of Pharmaceutical Sciences, Kotappakonda Rd, Narasaraopeta, Palnadu, Andhra Pradesh, India-522 601.
4 Malineni Perumallu College of Pharmacy, Pulladigunta+, Guntur-India.
Research Article
World Journal of Biology Pharmacy and Health Sciences, 2024, 19(01), 095–102.
Article DOI: 10.30574/wjbphs.2024.19.1.0409
Publication history:
Received on 01 June 2024; revised on 07 July 2024; accepted on 10 July 2024
Abstract:
The primary aim of the study was to enhance the dissolution rate of fenofibrate, a poorly soluble drug classified under BCS class II. To achieve this, solid dispersions were formulated using the dropping method with polyethylene glycol (PEG) 4000 and PEG 6000 at ratios of 1:1 and 1:2. These formulations were encapsulated and subjected to various evaluations, including solubility tests, assays, FTIR, X-ray diffraction (XRD), differential scanning calorimetry (DSC), and in-vitro dissolution studies. The most effective formulation was then compared to a commercially available product.
The formulation identified as D4, which utilized PEG 6000 at a 1:2 ratio via the dropping method, exhibited the highest solubility at 0.678 ± 0.07 mg/ml, a significant improvement over the pure drug's solubility of 0.018 mg/ml. The assay of D4 showed 98.14 ± 12%, with a practical yield of 95.25 ± 0.17%. In vitro dissolution testing revealed that the solid dispersions released the drug within 60 minutes, while the D4 formulation achieved a release of 99.10 ± 0.18% in just 30 minutes. This performance was notably superior to the pure drug, which had a release rate of 27.38 ± 0.10% in 60 minutes, and comparable to the marketed micronized fenofibrate capsule (Lipicard), which had a release rate of 93.91 ± 0.12% in 30 minutes.
FTIR analysis indicated no interaction between the drug and the excipients, while XRD and DSC studies confirmed that the drug in the solid dispersion was in an amorphous state. The optimized formulations demonstrated stability over time. Thus, employing the dropping method with a minimal carrier ratio of 1:2 significantly improved the drug release profile, making it comparable to the micronized fenofibrate (Lipicard).
Keywords:
Solid Dispersion; PEG 6000; PEG 4000; The Dropping Method; Fenofibrate
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0